Protective effect of EGCG on experimental diabetic nephropathy in rats

Chinese Pharmacological Bulletin

Volumn 22, Issue 1, 2006, Pages 84-88

  Yang, Xiao ^a   Li, Cai Rong ^a   Zhu, Zhong Hua ^a   Su, Hua ^a   Lu, Yuan Hang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diabetic nephropathy; EGCG; Homocysteine; Matrix metalloproteinase 9; Oxidative stress

Indexed keywords

ALBUMIN; CREATININE; EPIGALLOCATECHIN GALLATE; GELATINASE B; HOMOCYSTEINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG ACTIVITY; DRUG INHIBITION; EXPERIMENTAL DIABETES MELLITUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

EID: 33646190267     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hanson N Q, A ras O, Yang F et al. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reduetase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease[J]. Clin Chem, 2001,47(4):661-6.
2. Hoogeveen E K, Kostense P J, Jager A et al. Serum homocysteine level and protein in intake are related to risk of microalbum inuria: The Room Study[J]. Kidney Int, 1998,54(1):203-9.
3. Chico A, Perez A, Cordoba A et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetic nephropathy and cardiovascular disease[J]. Diabetologia, 1998,41(6):684 -93.
4. Urushihara M, Kagami S, Kuhara T et al. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human giomerulonephritis[J]. Nephrol Dial Transplant, 2002,17(7):1189 -96.
5. Shankland SJ, Scholey JW, Ly H et al. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy[J]. Kidney Int, 1994,46(2):430-42.
6. Fujisawa G, Okada K, Muto S et al. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats[J]. Kidney Int, 2004,66(4):1493-502.
7. Chyu KY, Bahbidge SM, Zhao X et al. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice[J]. Circulation, 2004, 109 (20): 2448-53.
8. Viberti GC, Hill RD, Jarrett RJ et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus[J]. Lancet, 1982,1(8287):1430-2.
9. Chang EJ, Mun KC. Effect of epigallocatechin gallate on renal function in cyclosporine-induced nephrotoxicity[J]. Transplant Proc, 2004,36(7):2133-4.
10. McLennan SV, Martell SY, Vue DK. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells; possible role in mesangium accumulation[J]. Diabetologia, 2000,43(5):642-8.